Vertex Pharmaceuticals Inc. buy Citigroup Inc.
Start price
14.11.24
/
50%
€470.80
Target price
14.11.25
€545.96
Performance (%)
-21.91%
Price
21.10.25
€367.65
Summary
This prediction is currently active. The prediction for Vertex Pharmaceuticals Inc. disappoints with a performance of -21.91%. This prediction currently runs until 14.11.25. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 3.461% | 3.461% |
| iShares Core DAX® | 0.299% | 2.868% |
| iShares Nasdaq 100 | 2.257% | 3.363% |
| iShares Nikkei 225® | 5.054% | 8.119% |
| iShares S&P 500 | 1.414% | 2.409% |
Comments by Citigroup_Inc_ for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $575.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€346.50
02.10.25
02.10.25
€489.84
02.10.26
02.10.26
6.10%
21.10.25
21.10.25
